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Introduction 
Brain-derived neurotrophic factor (BDNF) was first purified 
from the mammalian brain [1], and it’s the second member of the 
neurotrophin family next to the nerve growth factor (NGF) [2]. BDNF is 
widely accepted to regulate neuronal survival, differentiation, dendritic 
morphology, and synaptic plasticity [3,4]. It has been implicated for 
the differentiation and survival of the CNS neurons, because of the 
most abundant and widespread expression not only in the developing 
brain but also in the adult mammalian brain [5]. Furthermore, BDNF 
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 Abstract
Background: Polyunsaturated fatty acids (PUFA) are known to be crucial for learning and memory. However, 
the detailed mechanism of PUFA effects upon neuronal functions remains almost unknown except for the possible 
facilitation of membrane fluidity. G-protein coupled receptor 40 (GPR40) was found to induce Ca2+ mobilization 
in response to diverse PUFA. Thereafter, the authors found GPR40 expression in the newborn neurons of the 
monkey hippocampus after ischemia. This suggested implications of PUFA-mediated GPR40 signaling for adult 
neurogenesis underlying learning and memory.
Objective: This study aims at evaluating whether PUFA-mediated GPR40 activation can affect synthesis of 
brain-derived neurotrophic factor (BDNF) with the aid of its proteolytic enzyme furin. 
Methods: Monkeys underwent 20 min transient whole brain ischemia by clamping both the innominate and 
left subclavian arteries. On days 7 and 15 after ischemia/reperfusion, when adult neurogenesis was shown to be 
maximal previously by the authors, the brain samples were resected. By the Western blotting analysis of mature-BDNF 
(m-BDNF), pro-BDNF and furin, syntheses of BDNF in response to two GPR40 agonists as well as selective GPR40 
antagonist GW1100, were studied using normal and post-ischemic monkey dentate gyrus (DG) tissue extracts. 
Results: Both up-regulation of m-BDNF synthesis in response to two GPR40 agonists; fish oil PUFA and 
docosahexaenoic acid (DHA) and its down-regulation in response to GW1100, were observed. GPR40 antagonist 
inhibited m-BDNF synthesis, whereas two GPR40 agonists stimulated m-BDNF synthesis conceivably via furin 
activation. Cleavage of p-BDNF to m-BDNF by furin as well as syntheses of m-BDNF and furin in the DG tissues, 
occurred immediately after incubation with fish oil PUFA or DHA. Dynamic changes of GPR40, m-BDNF synthesis, 
and furin occurred simultaneously.
Conclusions: These data, although correlative, suggested that m-BDNF may be synthesized by the cleavage 
of pre-stocked pro-BDNF and/or released from the cell store in response to PUFA. By activating GPR40 and furin, 
PUFA may be related to adult neurogenesis and the concomitant synaptic plasticity for learning and memory. To 
the best of our knowledge, this is the first report suggesting a role of GPR40 in PUFA-mediated m-BDNF synthesis.
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has a critical role in long-term potentiation (LTP) [6-8], and recently 
emerged as a regulator of adult neurogenesis and the concomitant 
synaptogenesis indispensable for learning and memory [9].
BDNF protein is synthesized intracellularly as a precursor, 32 kDa 
pro-BDNF (p-BDNF) and rapidly converted as the 14 kDa m-BDNF 
after the intracellular cleavage, and the converted m-BDNF, but not 
p-BDNF, accumulates/stored in the neuronal cells which is called as 
pre-stocked BDNF and is released upon stimulation [10]. Or, p-BDNF 
is secreted extracellularly, then cleaved to m-BDNF in the synaptic 
cleft [11]. The extent of the intra- versus extra-cellular processing of 
p-BDNF is unclear, but the secretion of p-BDNF predominates [12,13]. 
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p-BDNF and m-BDNF may have opposite biological effects; p-BDNF 
induces cell death whereas m-BDNF supports cell survival [14,15]. 
Once released into the synaptic cleft, p-BDNF binds preferentially to 
pan neurotrophin receptor p75NTR for facilitating pro-apoptotic effects 
and long-term depression (LTD), while m-BDNF binds preferentially 
to both pre- and post-synaptic TrkB receptors for facilitating pro-
survival effects and LTP [8,15]. p-BDNF and m-BDNF activate different 
intracellular messenger cascades and affect distinct cellular responses. 
Lack of precise knowledge about the mechanisms by which PUFA 
influence BDNF synthesis, may constitute a severe limitation in 
elucidating the mechanism of PUFA effects upon the higher cognitive 
functions and complex behaviours. Since deorphanization of GPR40 
in 2003 [16,17], however, our understanding of the basic molecular 
and cellular mechanisms of PUFA underlying learning and memory 
has considerably advanced. In primates GPR40 mRNA was found to 
be abundantly expressed in both the brain and the pancreas, while in 
rodents it was expressed mainly in the pancreas, being negligible in the 
brain. Accordingly, for the following decade most studies using rodent 
experimental paradigms were done to clarify the molecular mechanism 
of the insulin secretion, so until recently there were very few studies 
focusing the rodent brain [18]. 
Recently, Boneva and Yamashima [19] suggested in the ischemic 
monkey experimental paradigm that PUFA, GPR40, phosphorylated 
cAMP response element-binding protein (pCREB), and BDNF may 
be engaged in the same signaling pathway for promoting neurogenesis 
in the adult hippocampus. They speculated that PUFA initially bind 
to GPR40 and activate intracellular downstream messengers such as 
Gαq, PLC, and PKC. The resultant Ca2+ release from the endoplasmic 
reticulum (ER) may lead to activation of different protein kinases such 
as Ca2+/calmodulin-dependent protein kinase type IV (CaMKIV), 
protein kinase B (Akt), extracellular signal-regulated kinase (ERK1/2), 
or mitogen-activated protein kinase (MAPK), which phosphorylate 
CREB, a key transcription factor in various gene regulation including 
Bdnf. Accordingly, it is indispensable to elucidate the signaling 
mechanism of intracellular Ca2+ mobilization necessary for the 
synthesis of BDNF that is facilitated by PUFA. 
In this study, we focused implication of GPR40 for regulating BDNF 
synthesis in the monkey hippocampus. It was focused because of the two 
reasons; 1) Since the extent of GPR40 protein expression in the brain was 
much larger in primates compared to rodents [16,17,19-22], the monkey 
hippocampus was appropriate for studying dynamic changes at the protein 
level, and 2) it showed a remarkable up-regulation of adult neurogenesis 
on the 2nd week after ischemia, being in deep association with BDNF 
synthesis [19-23]. Since the PUFA-GPR40-CREB-BDNF signaling was 
already indicated in our ischemic monkey experimental paradigms, the 
monkey hippocampal tissues before and after the ischemic insult were 
focused for the present in vitro analysis to compare both. The effects of 
GPR40 activation and inhibition upon BDNF synthesis as well as cleavage 
of p-BDNF by its proteolytic enzyme furin, were studied by comparing the 
normal (non-ischemic) and post-ischemic dentate gyrus (DG) tissues after 
incubation with GPR40 agonists such as fish oil PUFA and DHA as well as 
its selective antagonist GW1100.
Materials and Methods
Animals
Surgical procedures and postoperative care of experimental 
animals were done with proper approval of Animal Care and Ethics 
Committee of Kanazawa University (Approval No.: AP-132874). 
They were performed in strict adherence with the guidelines of both 
the Animal Care and Ethics Committee of Kanazawa University and 
the National Institutes of Health (NIH) Guide for the Care and Use 
of Laboratory Animals. Maximum efforts were done to reduce animal 
suffering from the pain throughout the experiments with reference 
to the guidelines of the NIH and Kanazawa University’s Animal Care 
and Ethics Committee. We decided to use the monkey samples for this 
experiment, because of the two reasons mentioned above. Furthermore, 
the amino acid sequence of the macaque monkeys are approximately 
95% homologous with humans, being appropriate for both elucidating 
common molecular cascade with humans and utilizing various anti-
human antibodies. A total of 10 young adult (4–6 years of age) Japanese 
monkeys (Macaca fuscata) with body weight of 5–8 kg, being supplied 
by National Bio-Resource Project ‘‘Japanese Monkeys’’ (Approval No.: 
Okazaki No.1-117, Japan) were bred in air-conditioned cages under 
standard conditions of humidity and temperature with 12 h light: 12 h 
dark cycle, and were allowed free daily access to food and water.
Ischemic operation and sampling/tissue preparation
Ten monkeys were divided into control animals (n=4) undergoing 
sham-operation and ischemic animals (n=3 for each post-ischemic days 
7 and 15). Under general anesthesia, transient global brain ischemia was 
carried out as described previously [24-26]. Briefly, by the mediastinal 
approach after resecting the sternum, both the innominate and left 
subclavian arteries were clamped for 20 min under general anesthesia, 
according to the surgical procedure previously described [24,25]. A 
laser Doppler (Vasamedics, St. Paul MN) was used to demonstrate the 
effectiveness of clamping. Body temperature, pupil size, arterial blood 
pressure, and cerebral blood ﬂow were monitored. Thereafter, the 
blood circulation of the brain was resumed. Monkeys were sacriﬁced 
on different time points after the ischemic insult/reperfusion; days 7 
and 15, intracardial perfusion was done with 500 ml of ice-cold saline 
under general anesthesia, and the brain was quickly removed and cut 
into small samples after craniectomy. Dissected fresh samples of the 
hippocampal DG were immediately put into the liquid nitrogen and 
stored at -80°C until use.
GPR40 agonists and antagonist 
Extracted fish oil (PUFA No.3; Menhaden Fish Oil containing 
mixer of PUFAs; Table 1) was obtained from Supelco (Bellefonte, 
Sl.No. Name of the PUFA
1. cis-4,7,10,13,16,19-Docosahexaenoic acid methyl ester













15. 11,14-Octadecadienoic acid methyl ester
16. 9,11,14-Octadecatrienoic acid methyl ester
17. cis-11-Octadecenoic methyl ester
Table 1: PUFA composition of extracted fish oil (PUFA No.3; Menhaden Fish Oil).
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PA, USA), while DHA (cis -4,7,10,13,16,19- Docosahexaenoic acid) 
was obtained from Sigma (St Louis, Missouri, MO, U.S.A.). GPR40 
selective antagonist, GW1100 (ethyl 4-[5-{[2-(ethyloxy)-5pyrimidinyl]
methyl}-2- {[(4-fluorophenyl) methyl]thio}-4-oxo1(4H)- pyrimidinyl]
benzoate), was obtained from Cayman Chemical (Ann Arbor, MI, USA). 
Both agonists and antagonist were dissolved in 99.5% DMSO. Working 
solution was prepared with radio-immunoprecipitation assay (RIPA) 
buffer (50 mM Tris, pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% NaDOC, 
0.1% SDS) (Sigma) at the concentration of 10 μM in all in vitro studies.
Diverse PUFA including DHA are well known endogenous in 
vitro agonists/ligands for GPR40 receptor [17-19,27], which are highly 
abundant in Fish oil compared to other animal sources. GW1100 is 
very highly selective antagonist of GPR40 being 1000 time specific for 
the GPR40 receptor [18,27]. These are the reason for the selection of 
these agonists/antagonist for this in vitro study.
Incubation of tissue extracts with agonists or antagonist 
The hippocampal DG tissues stored at -80°C were thawed/lysed on 
ice for 45 min and then homogenized by ultrasonic disruption in RIPA 
buffer without addition of any protease inhibitors, and centrifuged 
at 120 x 100 g at 4°C for 20 min to obtain whole tissue lysates. The 
supernatant was collected and protein concentration was measured by 
the Bradford assay. Incubation of the tissue extracts was done according 
to the method previously described by Ho et al. [28] with slight 
modification. Briefly, 10 μL of agonists/antagonist at the concentration 
of 10 μM were added to 10 μg total protein of tissue extracts, mixed 
well, and incubated for 30 min, 60 min, 90 min at 37°C. 1 M DTT was 
added to the samples for 30 min on ice to stop the reaction, then SDS-
loading buffer was added and boiled for 5-10 min at 99°C, mixed well, 
and served for the Western blotting analysis. Control samples were not 
incubated with agonist/antagonist; they were diluted 1:1 with SDS-
loading buffer containing 1M DTT and boiled for 5-10 min at 99°C, 
mixed well, and served for the Western blotting analysis. 
Different incubation time points were fixed based on our previous 
study results [21], showing that 10 μM of PUFA/DHA induced PLC/
PKC/PI3 signaling pathway and increases Ca2+ mobilization in rat 
neural stem cells transfected with GPR40 gene. Here, we tested various 
concentration/dose levels (5, 10 and 20 μM) of agonists/antagonist and 
then optimized to 10 μM throughout the study.
Antibodies
For the Western blotting analysis, the following antibodies were 
used as a primary antibody: rabbit anti-human BDNF (Sigma-Aldrich, 
St. Louis, MO) (1:1,000); rabbit anti-human pro-BDNF (Sigma, St. 
Louis, MO) (1:500); rabbit anti-human furin (Sigma-Aldrich, St. Louis, 
MO) (1:5,000); mouse anti-β Actin (Sigma, St. Louis, MO) (1:10,000). 
The following horseradish peroxidase-conjugated antibodies were used 
as a secondary antibody: goat anti-rabbit IgG (Sigma, St. Louis, MO) 
(1:3,000 and 1:5,000), and goat anti-mouse IgG (Santa Cruz, Santa 
Cruz, CA) (1:10,000). 
We have cross checked the antibodies for their specific expression. 
The rabbit anti-human BDNF antibody used in this study is more 
specific and detected only m-BDNF protein and not cross-reacted 
with p-BDNF protein, likewise rabbit anti-human pro-BDNF antibody 
detected only p-BDNF protein and not cross-reacted with m-BDNF 
protein in the tested samples.
Western blotting
For the electrophoresis, 10 μg total protein of each samples 
were run on 12% SDS acrylamide gel for 2 h, and 30 min at the 
constant voltage condition. The protein was transferred to hybond 
polyvinylidene fluoride (PVDF) nitrocellulose membrane using 
Trans-Blot Turbo Transfer pack and Trans-Blot Turbo Blotting System 
according to the manufacturer’s instructions (Bio-Rad, USA). Then, the 
membrane was blocked with 10% (w/v) non-fat skim milk in TBS-T 
(Tris-buffered saline/0.5% Tween 20) at room temperature (22°C) for 
1h. Primary antibody was diluted in the blocking solution (5% (w/v) 
non-fat skim milk in TBS-T) and incubated overnight at 4°C. On the 
following day, the membrane was rinsed three times in TBS-T. The 
respective horseradish peroxidase-conjugated secondary antibody was 
added and incubated at room temperature for 1 h. The membrane was 
rinsed, and Amersham ECL select Western blotting detection reagent 
(GE Healthcare Limited, Buckinghamshire, UK) was added for 5 
min to visualize the immunoreactive bands. The signal development 
was performed on a ﬁlm (Amersham Hyperﬁlm ECL; GE Healthcare 
Limited, UK). Using specific antibodies, m-BDNF was detected at 14 
kDa, p-BDNF at 32 kDa, while furin was detected at 87-88 kDa. 
Image acquisition and statistical analysis
Densities of the protein bands were measured by ImageJ software. 
Results were shown as mean ± SEM of at least three independent 
experiments with 4 replicates each. Using GraphPad Prism 6 (Oberlin, 
San Deiego, CA, USA), the statistical signiﬁcance was determined 
by one-way ANOVA with Bonferroni’s post hoc test to compare the 
agonists/antagonist-incubated samples with the control, whereas two–
way ANOVA with Bonferroni’s post-test to compare the data between 
the two agonists and antagonist. Differences were considered signiﬁcant 
when P<0.05. 
Results
Two endogenous GPR40 agonists such as fish oil PUFA and 
DHA as well as selective GPR40 antagonist GW1100, were utilized to 
elucidate PUFA-GPR40 signaling for BDNF synthesis by comparing 
the non-ischemic and post-ischemic DG tissues. Based on our previous 
ischemic monkey experimental paradigms studies, we hypothesized 
that the post-ischemic DG tissues concomitant with up-regulation of 
hippocampal neurogenesis [19-23] might show more BDNF synthesis 
in vitro in response to agonists, compared to the non-ischemic DG 
tissues. 
Effects of GPR40 agonists/antagonist upon BDNF synthesis 
in the non-ischemic DG tissues
To elucidate the potential link between GPR40 activation/inhibition 
and BDNF synthesis, dynamic changes in the protein levels of both 
m-BDNF (14 kDa) and p-BDNF (32 kDa) were studied, using specific 
antibodies. The m-BDNF protein showed a robust increase immediately 
after 30 min incubation in response to the two putative endogenous 
agonists of GPR40 receptors such as fish oil PUFA or DHA, compared 
to their corresponding controls (Figure 1A, 1B and 1D). The extent of 
increment of m-BDNF synthesis was higher in fish oil PUFA (> 2 fold at 
all incubation time points) than DHA (approximately 1.6 fold at 30 min 
and 60 min), compared to their corresponding controls (ANOVA with 
Bonferroni’s post hoc test; P<0.05). These data indicate that synthesis of 
m-BDNF might not be dependent on the incubation time in in vitro. On 
the contrary, p-BDNF showed a significant (ANOVA with Bonferroni’s 
post hoc test; P<0.05) decrease after incubation with fish oil PUFA or 
DHA at all time points (Figure 2A, 2B and 2D). 
Next, to confirm that the BDNF synthesis was mediated by GPR40, 
its selective antagonist GW1100 for the GPR40 receptor [18,27], was 
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Figure 1: Western blots of m-BDNF expression by non-ischemic dentate gyrus (DG) tissues incubated with GPR40 endogenous agonists such as fish oil PUFA (A) 
or DHA (B), and its antagonist GW1100 (C). Statistical analysis (D) of the respective m-BDNF/β-Actin ratio (mean ± SEM from three independent experiments with 
4 replicates each; (*P<0.05 versus control; ANOVA with Bonferroni’s post hoc test) revealed both a robust increase of m-BDNF immediately after 30 min incubation 
with both fish oil PUFA (A) or DHA (B), and a significant down-regulation of m-BDNF after incubation with GW1100 at 60 min and 90 min (C), compared to their 
corresponding controls. The extent of m-BDNF increment was more remarkable in fish oil PUFA than DHA. 
PUFA - + + +
IT (min) - 30 60 90
DHA - + + +
IT (min) - 30 60 90
GW1100 - + + +






Figure 2: Western blots of p-BDNF expression by non-ischemic DG tissues incubated with GPR40 endogenous agonists such as fish oil PUFA (A) or DHA (B), and its 
antagonist GW1100 (C). Statistical analysis (D) of the respective p-BDNF/β-Actin ratio (mean ± SEM from three independent experiments with 4 replicates each; (*P 
<0.05 versus control; ANOVA with Bonferroni’s post hoc test) revealed both a significant decrease of p-BDNF after incubation with both fish oil PUFA (A) or DHA (B), 
and no significant change in p-BDNF level after incubation with GW1100 (C), compared to their corresponding controls. 
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used to inhibit the GPR40 function/activation. The m-BDNF synthesis 
showed a significant down-regulation at 60 min (approximately 0.6 
fold) and 90 min (approximately 0.5 fold) after incubation, compared 
to the control (Figure 1C and 1D). On the contrary, p-BDNF showed 
no significant changes (Figure 2C and 2D) (ANOVA with Bonferroni’s 
post hoc test; P<0.05). These data indicate that the selective antagonist 
completely inhibited GPR40 function which in-turn prevented the 
synthesis of m-BDNF but not p-BDNF. The m-BDNF synthesis might 
be mediated by GPR40 while p-BDNF synthesis was unrelated to the 
GPR40 receptors or might not be mediated by GPR40 receptors.
Effects of GPR40 agonists/antagonist upon BDNF synthesis 
in the post-ischemic DG tissues
Since the m-BDNF synthesis was shown to be mediated by GPR40 
in the non-ischemic DG tissues, the same experiments were done 
using the post-ischemic DG tissues to clarify whether the in vitro 
BDNF synthesis increases concomitant with in-vivo up-regulation of 
adult neurogenesis (based on our previous studies) after ischemia [19-
23]. We focused on the post-ischemic day 7 and day 15 samples for 
this purpose, because newborn neurons in the monkey hippocampus 
showed a remarkable increase on the 2nd week after ischemia in our 
previous experimental paradigm studies [19,20].
In response to two agonists of fish oil PUFA and DHA, a remarkable 
up-regulation of the m-BDNF synthesis was found on the both post-
ischemic day 7 (approximately 1.7 fold for both agonists) (Figure 
3A, 3B and 3D) and post-ischemic day 15 (Figure 5A, 5B and 5D), 
compared to the controls (ANOVA with Bonferroni’s post hoc test; 
P < 0.05). On day 15, DHA showed a higher increment of m-BDNF 
synthesis (approximately 3 fold at 30 min; 4 fold at 90 min) then fish oil 
PUFA (approximately 1.7 fold at 30 min; > 2 fold at both 60, 90 min) 
compared to the corresponding controls. On the contrary, p-BDNF 
showed a significant (ANOVA with Bonferroni’s post hoc test; P<0.05) 
down-regulation on both post-ischemic day 7 (Figure 4A, 4B and 4D) 
and day 15 (Figure 6A, 6B and 6D), compared to the corresponding 
controls. On day 15, fish oil PUFA showed remarkable decrease (almost 
0.5 fold) in the p-BDNF levels compared to DHA. The extent of down-
regulation was stronger on day 15 than day 7 (by comparing their 
fold decrements). These results indicate that PUFA may act as GPR40 
receptor agonist to mediate synthesis of m-BDNF with consumption of 
p-BDNF especially in the post-ischemic DG tissues. 
To confirm that the BDNF synthesis was mediated by GPR40 also 
in the post-ischemic tissues, the inhibition experiment using GW1100 
was done. The m-BDNF protein showed a significant down-regulation 
on the post-ischemic day 7 (approximately 0.5 fold at 90 min), compared 
to the control (Figure 3C and 3D). In contrast, the post-ischemic day 
15 showed the most drastic down-regulation of m-BDNF at each time 
points (0.3 fold at 30 min; 0.1 fold at both 60, 90 min) compared to the 
control (ANOVA with Bonferroni’s post hoc test; P<0.05) (Figure 5C 
and 5D). Interestingly, p-BDNF showed no significant changes on both 
the post-ischemic day 7 (Figure 4C and 4D) and day 15 (ANOVA with 
Bonferroni’s post hoc test; P<0.05) (Figure 6C and 6D), presumably 
because absence of its consumption. These data indicate that GPR40 
antagonist completely inhibited activation of GPR40 in the ischemic 
DG tissues also to prevent synthesis of m-BDNF but not p-BDNF. The 
m-BDNF synthesis, might be mediated by GPR40 in both the normal 
and post-ischemic DG tissues, but p-BDNF synthesis, might not be 
mediated by GPR40 or unrelated to the GPR40 receptors in both the 
normal and post-ischemic DG tissues.
While comparing fold increment or decrements, day 15 post-
ischemic tissues showed more drastic synthesis of m-BDNF or strong 
decrease of p-BDNF compared to the day 7 and non-ischemic tissues.
Effects of GPR40 agonists/antagonist upon synthesis/
expression of furin in the non-ischemic DG tissues
To confirm whether the synthesis of m-BDNF protein occurred 
via cleavage of p-BDNF by furin in response to the GPR40 signaling, 
Figure 3: Western blots of m-BDNF expression by post-ischemic day 7 DG tissues incubated with GPR40 endogenous agonists such as fish oil PUFA (A) or DHA (B), 
and its antagonist GW1100 (C). Statistical analysis (D) of the respective m-BDNF/β-Actin ratio (mean ± SEM from three independent experiments with 4 replicates 
each; (*P<0.05 versus control; ANOVA with Bonferroni’s post hoc test) revealed both a remarkable up-regulation of m-BDNF after incubation with both fish oil PUFA 
(A) or DHA (B), and a significant down-regulation of m-BDNF after incubation with GW1100, being maximal at 90 min (C), compared to their corresponding controls.
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Figure 4: Western blots of p-BDNF expression by post-ischemic day 7 DG tissues incubated with GPR40 endogenous agonists such as fish oil PUFA (A) or DHA (B), 
and its antagonist GW1100 (C). Statistical analysis (D) of the respective p-BDNF/β-Actin ratio (mean ± SEM from three independent experiments with 4 replicates each; 
(*P<0.05 versus control; ANOVA with Bonferroni’s post hoc test) revealed both a significant down-regulation of p-BDNF after incubation with both fish oil PUFA (A) or 
DHA (B), and no significant changes in p-BDNF level after incubation with GW1100 (C), compared to their corresponding controls.
Figure 5: Western blots of m-BDNF expression by post-ischemic day 15 DG tissues incubated with GPR40 endogenous agonists such as fish oil PUFA (A) or DHA 
(B), and its antagonist GW1100 (C). Statistical analysis (D) of the respective m-BDNF/β-Actin ratio (mean ± SEM from three independent experiments with 4 replicates 
each; (*P<0.05 versus control; ANOVA with Bonferroni’s post hoc test) revealed both a remarkable up-regulation of m-BDNF after incubation with both fish oil PUFA (A) 
or DHA (B), and the most drastic down-regulation of m-BDNF at each time points after incubation with GW1100, from 30 min to 90 min, being maximal at both 60 min 
and 90 min (C), compared to their corresponding controls. DHA showed the more remarkable increase than fish oil PUFA, being maximal at 90 min.
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Figure 6: Western blots of p-BDNF expression by post-ischemic day 15 DG tissues incubated with GPR40 endogenous agonists such as fish oil PUFA (A) or DHA 
(B), and its antagonist GW1100 (C). Statistical analysis (D) of the respective p-BDNF/β-Actin ratio (mean ± SEM from three independent experiments with 4 replicates 
each; (*P<0.05 versus control; ANOVA with Bonferroni’s post hoc test) revealed both a significant down-regulation of p-BDNF after incubation with both fish oil PUFA 
(A) or DHA (B), and no significant changes in p-BDNF level after incubation with GW1100 (C), compared to their corresponding controls. Fish oil PUFA showed the 
more remarkable decrease in p-BDNF levels than DHA.
PUFA - + + +
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DHA - + + +
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Figure 7: Western blots of furin expression by non-ischemic DG tissues incubated with GPR40 endogenous agonists such as fish oil PUFA (A) or DHA (B), and its 
antagonist GW1100 (C). Statistical analysis (D) of the respective Furin/β-Actin ratio (mean ± SEM from three independent experiments with 4 replicates each; (*P< 
0.05 versus control; ANOVA with Bonferroni’s post hoc test) revealed both a strong, gradual increase of furin from 30 min to 90 min incubation with both fish oil PUFA 
(A) or DHA (B), and a significant down-regulation of furin after incubation with GW1100 at all time points (C), compared to their corresponding controls. The extent of 
of furin increment was more remarkable in fish oil PUFA than DHA.
dynamic changes in the levels of furin protein (87-88 kDa) were 
studied in the non-ischemic DG tissues, using a specific antibody. Furin 
showed a strong and gradual increase after 30~90 min incubation with 
the two GPR40 agonists such as fish oil PUFA or DHA, compared to 
their corresponding controls (ANOVA with Bonferroni’s post hoc test; 
P<0.05) (Figure 7A, 7B and 7D). Fish oil PUFA showed a very strong 
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and gradual increase of furin (approximately 1.5 fold at 30 min; 2.5 fold 
at 90 min) than DHA (approximately 1.4 fold at 30 min; 1.8 fold at 90 
min), compared to their corresponding controls.
Next, to confirm that the BDNF synthesis by furin was mediated 
by GPR40, its selective antagonist GW1100 was used to inhibit 
the GPR40 function/activation. Furin showed a significant down-
regulation immediately after 30 min (0.7 fold) and 60 min and 90 min 
(approximately 0.5 fold) after incubation, compared to the control 
(ANOVA with Bonferroni’s post hoc test; P<0.05) (Figure 7C and 7D). 
These data indicate that the selective antagonist completely inhibited 
GPR40 function to down-regulate furin or reduce the furin protein 
levels, and that furin may be related to the BDNF synthesis via GPR40 
signaling.
Effects of GPR40 agonists/antagonist upon synthesis/
expression of furin in the post-ischemic DG tissues
Since the m-BDNF synthesis by furin was shown to be mediated 
by GPR40 in the normal DG tissues, the same experiments were 
done using the post-ischemic DG tissues (day 7 and day 15) to clarify 
whether increment of the BDNF synthesis occur concomitant with up-
regulation of furin after ischemia. 
Remarkable up-regulation of furin was found on both post-
ischemic day 7 (approximately 1.3 fold at 30 min; 1.5 fold at 90 min 
in response to the two agonists) (Figure 8A, 8B and 8D) and post-
ischemic day 15 (fish oil PUFA showed a higher increment of furin 
(approximately 1.6 fold at 30 min; 2.1 fold at 90 min) then DHA (1.2 
fold at 30 min; approximately 1.6 fold at 90 min)), compared to the 
controls (ANOVA with Bonferroni’s post hoc test; P<0.05) (Figure 
9A, 9B and 9D). The extent of up-regulation was stronger on day 15 
than day 7 (by comparing their fold increment). These results suggest 
that PUFA may act as GPR40 receptor agonist to mediate synthesis of 
m-BDNF with the aid of furin especially in the post-ischemic tissues. 
DHA - + + +
IT (min) - 30 60 90
GW1100 - + + +
IT (min) - 30 60 90
PUFA - + + +




Figure 8: Western blots of furin expression by post-ischemic day 7 DG tissues incubated with GPR40 endogenous agonists such as fish oil PUFA (A) or DHA (B), 
and its antagonist GW1100 (C). Statistical analysis (D) of the respective Furin/β-Actin ratio (mean ± SEM from three independent experiments with 4 replicates each; 
(*P<0.05 versus control; ANOVA with Bonferroni’s post hoc test) revealed both a remarkable up-regulation of furin after incubation with both fish oil PUFA (A) or DHA 
(B), and a significantly gradual down-regulation of furin after incubation with GW1100 being maximal at 90 min (C), compared to their corresponding controls.
Next, to confirm that m-BDNF synthesis by furin was mediated by 
GPR40 in the post-ischemic tissues also, the antagonist experiment was 
done. Furin showed a significant down-regulation on the post-ischemic 
day 7 (approximately 0.6 fold (30 min), 0.4 fold (60 min), and 0.35 fold 
(90 min)), compared to the control (ANOVA with Bonferroni’s post 
hoc test; P<0.05) (Figure 8C and 8D). In contrast, the post-ischemic 
day 15 showed very strong down-regulation of furin at each incubation 
time (0.6 fold at 30 min; 0.3 fold at both 60 and 90 min) (ANOVA with 
Bonferroni’s post hoc test; P<0.05) (Figure 9C and 9D), compared to 
the control. These data indicate that GPR40 antagonist completely 
inhibited GPR40 function which in-turn prevented the furin protein to 
cleave the stock p-BDNF into m-BDNF in the post-ischemic DG tissues 
also. The m-BDNF synthesis by furin might be mediated by GPR40 
receptors in both the normal and post-ischemic DG tissues.
While comparing fold increment, both day 15 post-ischemic tissues 
and the non-ischemic tissues showed more drastic expression of furin 
compared to the day 7 post-ischemic tissues.
Discussion
In this study, we demonstrated that (1) the m-BDNF synthesis 
was mediated by GPR40 in both the normal (non-ischemic) and 
post-ischemic DG tissues, (2) the m-BDNF synthesis occurred more 
drastically in the day 15 post-ischemic tissues, compared to the day 7 
and non-ischemic tissues while comparing their fold increment/up-
regulation, (3) the furin expression/synthesis was also mediated by 
GPR40 in both the normal and post-ischemic DG tissues, (4) the furin 
expression/synthesis also occurred more drastically in both the day 15 
post-ischemic tissues and the non-ischemic tissues, compared to the 
day 7 post-ischemic tissues, (5) similarly, the decrease (consumption/
cleavage) of p-BDNF was the most remarkable on day 15, (6) cleavage 
of p-BDNF to m-BDNF by furin as well as syntheses of m-BDNF and 
furin in the DG tissues occurred immediately, within 30 minutes, after 
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Figure 9: Western blots of furin expression by post-ischemic day 15 DG tissues incubated with GPR40 endogenous agonists such as fish oil PUFA (A) or DHA (B), 
and its antagonist GW1100 (C). Statistical analysis (D) of the respective Furin/β-Actin ratio (mean ± SEM from three independent experiments with 4 replicates each; 
(*P<0.05 versus control; ANOVA with Bonferroni’s post hoc test) revealed both a remarkable up-regulation of furin after incubation with both fish oil PUFA (A) or DHA 
(B), and a very strong down-regulation of furin at each time points after incubation with GW1100, from 30 min to 90 min, being maximal at both 60 min and 90 min (C), 
compared to their corresponding controls. Fish oil PUFA showed the more remarkable increase than DHA, being maximal at 90 min.
Figure 10: Schematic flow chart of the PUFA-GPR40-BDNF signaling pathway. Initially, PUFA bind to GPR40 and presumably activate intracellular downstream 
messengers such as Gαq, PLC, and PKC that results in Ca2+ release from the ER [21]. Increased Ca2+ levels lead to activation of different protein kinases such as 
CaMKIV, Akt, ERK1/2, or MAPK which phosphorylate CREB, a key transcription factor in various gene regulation including Bdnf [18,19,23]. These activation finally 
leads to synthesis of m-BDNF either by (i) cleavage of p-BDNF to m-BDNF intracellularly by furin etc., or (ii) stimulating neurons, astrocytes and glial cells etc. to 
release m-BDNF from the internal cell stores. These two processes lead to increment of m-BDNF synthesis and decrease of p-BDNF levels for regulating Bdnf 
gene transcription. This, in turn, regulates adult neurogenesis, synaptic plasticity, learning and memory. Gαq, G protein subunits α, q; Akt, protein kinase B; BDNF, 
brain-derived neurotrophic factor; CaMKIV, Ca2+/calmodulin-dependent protein kinase type IV; CREB, cAMP response element-binding protein; ER, endoplasmic 
reticulum; ERK1/2, extracellular signal-regulated kinase; GPR40, G protein-coupled receptor 40; MAPK, mitogen-activated protein kinase; pCREB, phosphorylated 
cAMP response element-binding protein; PKC, protein kinase C; PLC, phospholipase C; PUFA, polyunsaturated fatty acids.  
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incubation with fish oil PUFA or DHA, and (7) the syntheses of both 
m-BDNF and furin were significantly inhibited by the selective GPR40 
antagonist, which was maximal on day 15. 
These findings suggest that (i) there may be a close relation between 
activation of GPR40 receptors and m-BDNF synthesis, but not with 
p-BDNF synthesis, and that (ii) the proteolytic cleavage of p-BDNF to 
m-BDNF occurs presumably by furin in the DG tissues in response to 
the PUFA signals via GPR40 receptors. It is reasonable that both the 
p-BDNF decrease and the concomitant increment of both m-BDNF 
and furin were the most remarkable on day 15 after ischemia. Although 
later time point (90 min) showing slight decrease in synthesis of 
m-BDNF with fish oil PUFA, but considering overall synthesis of both 
m-BDNF and furin with concomitant cleavage/decrease of p-BDNF 
were highly remarkable on day 15 after ischemia in response to the two 
agonists, fish oil PUFA and DHA while comparing to the day 7 post-
ischemic and normal (non-ischemic) DG tissues. This is presumably/
probably because adult hippocampal neurogenesis peaked on day 15 
which is shown by our previous monkey experimental paradigms 
studies [19,20,22], and m-BDNF was the most necessary for the 
neuronal differentiation at this time point. 
The exact production/release sites of BDNF (either mature- or pro-
BDNF) are still unknown, because of both (i) the extremely low level 
of BDNF expression in most of the neuronal tissues, and (ii) lack of 
evidence regarding the subcellular localization of endogenous BDNF 
in neurons. However, endogenously-expressed BDNF were found 
[29,30] at highest levels in the presynaptic neuronal processes such 
as cortical axons projecting to the striatum, and in the hippocampal 
mossy ﬁbers projecting to CA3 pyramidal cells; whereas relatively low/
negligible levels were found [11] in the postsynaptic neuronal processes 
(hippocampal CA1 and cortical pyramidal neurons are few). It remains 
unelucidated whether endogenously-expressed BDNF is mainly located 
in axons (presynaptic) or dendrites (postsynaptic), or whether release of 
endogenous BDNF occurs from both. Accordingly, the ultimate answer 
to the production/release site of endogenously-expressed BDNF would 
not be available until an appropriate staining procedure can detect a 
single BDNF vesicle at the endogenous expression level in the living 
tissue [31]. 
BDNF is synthesized as a precursor 32 kDa p-BDNF protein, 
proteolytically cleaved by enzymes like furin or pro-convertases 
intracellularly, and released as the 14 kDa m-BDNF [31,32]. It is 
possible that other proteases except for furin, may be activated by the 
internal Ca2+ mobilization and implicated for the p-BDNF cleavage. 
Since the present data showed that increases of m-BDNF and furin 
concomitant with a decrease of p-BDNF occurred in both the normal 
and post-ischemic DG tissues in response to the two agonists, it is 
probable that GPR40 activation stimulated furin to cleave p-BDNF 
to m-BDNF intracellularly. Likewise, p-BDNF might be secreted 
extracellularly and might be cleaved by metalloproteinases and/
or plasmin to m-BDNF [11,33]. Among four possible proteolytic 
enzymes that can be involved in p-BDNF cleavage including furin, pro-
convertases, metalloproteinases and plasmin, the strongest candidate 
that can be activated by PUFA-GPR40 signaling may be furin. However, 
altered levels in furin protein concentrations as shown here, but not 
actual increase of the enzyme activity, are not a conclusive evidence of 
GPR40-mediated furin enzyme activity. Additional experiments would 
strengthen role of furin, by demonstrating that specific inhibition of its 
enzyme activity leads to a loss of agonist-mediated increase in m-BDNF 
levels. 
It is well-known that furin cleaves p-BDNF to m-BDNF in the trans-
Golgi network to release m-BDNF there [10,31,34]. The present results 
using the DG tissues are in complete agreement with the previous 
reports. In the normal tissues, furin is expressed at very low levels, 
however, its up-regulation occurs in a variety of human cancers, because 
furin expression is enhanced during hypoxia in cancer cells [35,36]. In 
agreement with this, ischemia might be also a common pathological 
state in the brain that can enhance furin expression. For example, Yokota 
et al. [37] first reported that up-regulation of furin gene occurs twice in 
the rat hippocampus after transient global cerebral ischemia, compared 
to the control. Chen et al. [38] very recently analysed furin expression in 
the cultured astrocytes being exposed to the ischemia-like oxygen and 
glucose-deprivation, and observed a significant up-regulation of furin. 
They reported that furin-mediated BDNF up-regulation occurs after 
oxygen and glucose-deprivation. These reports [37,38] are consistant 
with the present results. Accordingly, it is likely that furin-mediated 
m-BDNF synthesis occurs via GPR40 activation in the post-ischemic 
DG tissues especially on the post-ischemic day 15 which is shown 
highest up-regulation of both in this study. Here, the two putative 
endogenous agonists of the GPR40 receptors such as fish oil PUFA and 
DHA remarkably activated furin and m-BDNF syntheses, while GPR40 
selective antagonist GW1100 completely inhibited syntheses of both. 
It may be reasonable to speculate that the PUFA-GPR40 molecular 
signaling acts as a trigger for activation and up-regulation of furin to 
synthesize m-BDNF from p-BDNF. Then, such a question emerges 
which molecular cascade was induced by the PUFA-GPR40 signaling 
as a trigger of furin up-regulation and activation?
Furin promoters are known to have putative binding sites for 
hypoxia-inducible factor-1 (HIF-1), a transcription complex that plays 
a pivotal role in the cellular adaptation to hypoxia. McMahon et al. 
[39] demonstrated that the levels of fur mRNA, encoding furin, were 
remarkably increased upon the hypoxic challenge, and that the hypoxic/
HIF-1 regulation of furin correlated with an increased proteolytic 
activation. The authors speculate that GPR40 activation at the in-vivo 
ischemic insult induced a rapid and sustained phosphorylation of 
endogenous p42/p44 MAPK. The downstream MAPK cascade elements 
enhanced nuclear translocation of mothers against decapentaplegic 
homolog 2 (Smad2), where it may interact with DNA-binding proteins 
and direct transcription of the fur gene [40]. In parallel, PUFA bind 
to GPR40 in vitro and trigger an intracellular cascade that results in 
Ca2+ release form the ER [19,21]. 1) Pre-stocked BDNF is reported by 
Matsumoto et al. [10] that p-BDNF is rapidly converted intracellularly 
to m-BDNF, and the converted m-BDNF, but not p-BDNF, accumulates 
in the neuronal cells and is released upon stimulation. 2) Since GPR40 
is also expressed in the glial cells in the monkey brain [20], it is also 
probable GPR40 stimulated also glial cell stores. It is coceivable that 
GPR40 receptors may not only stimulated furin to synthesize m-BDNF 
by p-BDNF cleavage, but also stimulated internal cell stores such 
as neurons, astrocytes and glial cell etc.. to release the pre-stocked 
m-BDNF. This are the two probable reasons in this in vitro study why 
some DG samples did not show a concomitant decrease in the p-BDNF 
protein level, despite the drastic/double fold increase of m-BDNF 
synthesis. 
In this study, m-BDNF synthesis from the cleavage of pre-stocked 
p-BDNF by furin and release of m-BDNF from the cell stores [10], 
occurred more drastically on the post-ischemic day 15 DG, compared 
to the non-ischemic controls and day 7 post-ischemic samples. This is 
probably because GPR40 up-regulation occurred most dramatically 
on day 15 after ischemia which is shown by previous studies [20], 
and up-regulated GPR40 being involved in the day 15 homogenized 
tissues could efficiently respond to the two ligands of fish oil PUFA or 
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DHA for inducing internal Ca2+ mobilization [22] necessary for both 
activating furin [37] and stimulating neurons, astrocytes and glial cell 
etc.. to release the stored m-BDNF. In-vivo up-regulation of furin and 
GPR40 in the day 15 DG, presumably occurred in response to the rapid 
in vitro Ca2+ mobilization from the remaining internal Ca2+ stores such 
as endoplasmic reticulum and mitochondria. These might facilitate 
furin-mediated cleavage of p-BDNF to m-BDNF and also release the 
pre-stocked m-BDNF.
By activating GPR40 and furin, PUFA may be related to adult 
neurogenesis, neuronal development and the concomitant synaptic 
plasticity for learning and memory. The present data provide one of the 
possible molecular mechanisms by which m-BDNF synthesis increases 
in the post-ischemic DG tissues, and thereby impacts bioavailability 
of GPR40 for synaptogenesis and synaptic plasticity in the newborn 
neurons. However, in response to conjugated linoleic acids or trans 
isomers of arachidonic acid, the non-esterified fatty acid receptor 
GPR40 was recently demonstrated in rodents to mediate lipotoxicity to 
neurons, microvessels, or β-cells [41]. Since non-esterified fatty acids in 
the blood are not infrequently elevated and/or oxidized excessively in 
the human subjects suffering from metabolic syndrome, type 2 diabetes, 
Alzheimer’s disease, Parkinson’s disease etc., the pharmacological 
effects of PUFA binding with GPR40 are extremely complex. It is likely 
that according to the extent of GPR40 activation, PUFA effects may be 
beneficial or detrimental. We must always keep in mind ‘dual effects 
of GPR40 for human health’ in response to diverse fatty acids. Since 
our understanding of the pharmacology of GPR40 in the brain is still 
incomplete, not only its physiological effects but also its pathological 
effects should be studied further (Figure 10).
Conclusion and Future Perspectives
In summary, we have demonstrated up-regulation of m-BDNF 
synthesis in response to two GPR40 agonists such as fish oil PUFA and 
DHA and its down-regulation in response to GPR40 selective antagonist 
GW1100 by using the normal and post-ischemic dentate gyrus (DG) 
tissues of monkey hippocampus. GPR40 antagonist inhibited m-BDNF 
synthesis but not p-BDNF, whereas both two GPR40 agonists stimulated 
m-BDNF synthesis conceivably via the enzyme furin. As simultaneous 
changes of GPR40, m-BDNF synthesis, and furin were observed, GPR40 
might be related to m-BDNF synthesis; however, implication of furin 
should be confirmed by further studies. Considering our previous studies 
along with the present data, we can conclude that 1) fish oil PUFA or DHA 
may be responsible for m-BDNF synthesis which is essential for regulating 
synaptogenesis and adult neurogenesis, and 2) this effect may be dependent 
on furin-dependent cleavage of p-BDNF to generate m-BDNF. 
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